Dose Escalation Study of Safety and Tolerability of AT-406 in Patients With Advanced Solid Tumors and Lymphomas
Clinical trial NCT01078649 · COMPLETED
Trial details
- NCT number
- NCT01078649
- Sponsor
- Debiopharm International SA
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-03-29
- Primary completion
- 2014-04-01
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.